Cadrenal Therapeutics, Inc. 10-Q filing
Filed 2025-11-10 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001213900-25-107816
- Form type
- 10-Q
- CIK
- 0001937993
- Primary document
- https://www.sec.gov/Archives/edgar/data/1937993/000121390025107816/ea0263343-10q_cadrenal.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Cadrenal Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-10.4M | - | - |
| Net Income | $-10.2M | - | - |
| Eps Basic | -5.23 | - | - |
| Eps Diluted | -5.23 | - | - |
| Cash And Equivalents | $3.9M | - | - |
| Total Assets | $4.1M | - | - |
| Total Liabilities | $1.4M | - | - |
| Shareholders Equity | $2.7M | - | - |
| Operating Cash Flow | $-10.0M | - | - |
| Capital Expenditures | $5,104 | - | - |